Evaluation of Different Diagnostic Methods of Tuberculosis in Assiut University Hospitals
1 other identifier
observational
166
0 countries
N/A
Brief Summary
- Detection of sensitivity and specificity of microscopic examination and Molecular studies using polymerase chain reaction (PCR) Mycobacterium tuberculosis (MTB)/ non tuberculous mycobacterium (NTM) MDR-TB compared to culture which is the gold standard technique in the diagnosis of TB to reach the most reliable one for better health care service.
- Assess the prevalence of tuberculosis cases among clinically suspected cases admitted to the hospital throughout the selected study period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 29, 2024
CompletedFirst Posted
Study publicly available on registry
October 31, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
ExpectedNovember 5, 2024
November 1, 2024
12 months
October 29, 2024
November 3, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
*Compare between different available tests to reach the most reliable one for better health care service.
\*Detection of sensitivity and specificity of microscopic examination and Molecular studies using PCR MTB/NTM MDR-TB compared to culture which is the gold standard technique in the diagnosis of TB to reach the most reliable one for better health care service.
two years
Secondary Outcomes (1)
*Assess the prevalence of tuberculosis cases among clinically suspected cases admitted to the hospital throughout the selected study period.
two years
Interventions
• The Polymerase chain reaction (PCR) MTB/NTM MDR-TB test is an innovative technology that offers a cutting-edge approach to the precise diagnosis of tuberculosis and nontuberculous mycobacterial infections (NTM).
Eligibility Criteria
Patients with signs and symptoms of tuberculosis (suspected cases) and Patients diagnosed with tuberculosis of both sexes admitted to Assiut university hospitals
You may qualify if:
- Patients with signs and symptoms of tuberculosis (suspected cases)
- Patients diagnosed with tuberculosis.
You may not qualify if:
- Patients with pulmonary infections other than TB
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Rakotosamimanana N, Rabodoarivelo MS, Palomino JC, Martin A, Razanamparany VR. Exploring tuberculosis by molecular tests on DNA isolated from smear microscopy slides. Int J Infect Dis. 2017 Mar;56:248-252. doi: 10.1016/j.ijid.2016.12.005. Epub 2016 Dec 12.
PMID: 27979786BACKGROUND
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- clinical pathology specialist
Study Record Dates
First Submitted
October 29, 2024
First Posted
October 31, 2024
Study Start
January 1, 2025
Primary Completion
December 30, 2025
Study Completion (Estimated)
September 30, 2026
Last Updated
November 5, 2024
Record last verified: 2024-11